StockData
Onconetix, Inc. logo

Onconetix, Inc. (ONCO) stock

ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$3.00+0.09 (+3.09%)

Close on Nov 17, 2026Market cap $11.85MP/E –Yield –

Onconetix cash

Cash and short-term investments held at the end of each period.

Onconetix's cash was $5.94M at Jun 30, 2026. For fiscal 2025 it was $5.22M, up 707.5% from the year before. The highest annual figure on record is $25.75M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.22M+707.5%
FY2024Dec 31, 2024$646.50K-85.8%
FY2023Dec 31, 2023$4.55M-82.3%
FY2022Dec 31, 2022$25.75M+1235.4%
FY2021Dec 31, 2021$1.93M-55.2%
FY2020Dec 31, 2020$4.31M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.94M+1995.9%
Q1 FY2026Mar 31, 2026$3.72M+135.6%
Q4 FY2025Dec 31, 2025$5.22M+707.5%
Q3 FY2025Sep 30, 2025$836.56K+145.0%
Q2 FY2025Jun 30, 2025$283.52K-69.5%
Q1 FY2025Mar 31, 2025$1.58M-64.7%
Q4 FY2024Dec 31, 2024$646.50K-85.8%
Q3 FY2024Sep 30, 2024$341.50K-95.5%
Q2 FY2024Jun 30, 2024$930.54K-89.9%
Q1 FY2024Mar 31, 2024$4.46M-82.7%
Q4 FY2023Dec 31, 2023$4.55M-84.4%
Q3 FY2023Sep 30, 2023$7.65M-65.6%
Q2 FY2023Jun 30, 2023$9.22M-50.4%
Q4 FY2022Dec 31, 2022$25.75M+1235.4%
Q3 FY2022Sep 30, 2022$29.14M+962.6%
Q2 FY2022Jun 30, 2022$22.24M+506.1%
Q1 FY2022Mar 31, 2022$18.61M+359.2%
Q4 FY2021Dec 31, 2021$1.93M-55.2%
Q3 FY2021Sep 30, 2021$2.74M–
Q2 FY2021Jun 30, 2021$3.67M–
Q1 FY2021Mar 31, 2021$4.05M–
Q4 FY2020Dec 31, 2020$4.31M–

More Onconetix figures

See a number that looks wrong?